Ferric citrate hydrate is associated with a reduced cost of drugs and a smaller change in red blood cell distribution width

The ASTRIO study was a randomised, multicentre, 24-week study that compared the effects of ferric citrate hydrate (FC) and non-iron-based phosphate binders (control) on anaemia management in haemodialysis (HD) patients receiving erythropoiesis-stimulating agents (ESAs). In that study, FC reduced the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Kyoko, Yokoyama, Keitaro, Nakayama, Masaaki, Fukagawa, Masafumi, Hirakata, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844010/
https://www.ncbi.nlm.nih.gov/pubmed/35165297
http://dx.doi.org/10.1038/s41598-022-06261-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844010/
https://www.ncbi.nlm.nih.gov/pubmed/35165297
http://dx.doi.org/10.1038/s41598-022-06261-0

Ejemplares similares